DSNKY (Daiichinkyo Co) Short Interest


DSNKY Daiichi Sankyo Co Ltd DSNKY
73 GF Score
Price $15.76
GF Value $39.38
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Daiichinkyo Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

DSNKY vs LLY, JNJ, ABBV: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daiichinkyo Co Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Short Interest falls into.


DSNKY
73GF Score
Daiichi Sankyo Co Ltd DSNKY
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Daiichinkyo Co (DSNKY) Overvalued in 2026?

Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued. The current stock price of $15.76 is trading 60% below its estimated GF Value™ of $39.38. GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.

Key valuation signals for DSNKY:

  • Short Interest:
  • GF Value™: $39.38 vs. price of $15.76 (60% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the DSNKY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daiichinkyo Co Business Description

Address 3-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
73GF Score

Get the complete analysis for DSNKY

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.76
Price
$39.38
GF Value